Address And Details

4 Manhattanville Rd, Ste 102 , Purchase, NY 10577
Fund Manager Robert A. Olstein
Manager Tenure 14 Years 10 Months

Strategy And Objective

The Olstein Strategic Opportunities Funds (the Fund or Strategic Opportunities Fund) investment objective is long-term capital appreciation and its secondary objective is income. The Fund seeks to achieve its objectives by investing primarily in common stocks of small- and mid-sized companies (small-cap or mid-cap stocks) that OCM believes are selling at a significant discount to private market value. The Fund uses several valuation methods to determine private market value, all of which emphasize expected future free cash flow. Future free cash flow represents the cash that a company is able to generate from operations after any required investment to maintain or expand its asset base (i.e., after required capital expenditures and working capital needs). For purposes of this investment policy, the Fund considers small- and mid-sized companies to be those with market capitalization values (share price multiplied by the number of shares of common stock outstanding) within the range represented in the Russell 2500TM Index (as of June 30, 2020, the Indexs weighted average market capitalization was approximately $4.74billion and the largest company in the Index had a market capitalization of approximately $14.16 billion).

Net Asset Value

as of 4:54 PM ET 09/17/2021

Performance

  • 1 Week
  • +0.41%
  • 1 Month
  • -1.37%
  • 3 Months
  • -2.24%
  • 1 Yr Return
  • +54.97%
  • 5 Yr Return
  • +83.09%

Equity Sector Breakdown

Finance 15.07%
ConsumerDurables 14.00%
RetailTrade 11.29%
IndustrialCyclical 11.21%
NonDurables 11.01%
Health 6.74%
Services 4.70%
Technology 3.96%
Energy n/a
Utilities n/a

Asset Allocation

Asset Type % Of Allocation
Stocks 78.86%
Cash 0.00%
Bonds 0.00%
Preferred 0.00%
Convertible 0.00%
Other 0.00%
ForeignStocks 0.00%
ForeignBonds 0.00%
ForeignHedged 0.00%
Total Net Assets 33.23 M

Risk Measures

Criteria 3 Years 5 Years 10 Years
Alpha -7.51 -8.61 -6.86
Beta 1.45 1.40 1.37
R Squared 0.80 0.75 0.76
Std Deviation 30.01 24.27 21.07
Sharpe Ratio 0.62 0.63 n/a

Purchase Information

as of 4:54 PM ET 09/16/2021
Minimum Initial $1000
Minimum Additional $100
Minimum Initial IRA $1000

Performance

Timeframe Average Annual Current Performance Monthly As Of 08/31/2021 Average Annual Current Performance Quarterly As Of 06/30/2021 Avg Annual Current Performance Monthly As Of 08/31/2021 Avg Annual Current Performance Quarterly As Of 06/30/2021
1 Year
  • +62.70%
  • +80.84%
+62.70% +80.84%
3 Year
  • +14.69%
  • +16.65%
+14.69% +16.65%
10 Year
  • +13.20%
  • +11.76%
+13.20% +11.76%
Life Of Fund
  • +9.03%
  • +9.13%
+9.03% +9.13%

Top 10 Holdings

Symbol Company Name % Of Assets
IVZ INVESCO LTD 4.08%
DISCA DISCOVERY INC 3.84%
WCC WESCO INTL INC 3.73%
PBH PRESTIGE CONSUMER HEALTHCARE 3.54%
CENT CENTRAL GARDEN & PET CO 3.40%
BLBD BLUE BIRD CORPORATION 2.83%
ST SENSATA TECHNOLOGIES HOLDING 2.67%
WRK WESTROCK COMPANY 2.61%
INS INTELLIGENT SYSTEMS CORP 2.59%
CFG CITIZENS FINANCIAL GROUP INC 2.57%

LATEST NEWS

Recent Articles from TheStreet

9/11 Lead

Cramer’s Recollections of 9/11

A beautiful day in New York City, Then the Unimaginable

Hong Kong Stocks Slump On Tech Sector Worries As US Official Signals Flaws In China Trade Deal

Intraday Reversals Signal Struggles for Market

But James "Rev Shark" Deporre says the trading action is both normal, and appropriate for September, and he's been adding some names to his portfolio.

stocks market index sh

Cramer's Mad Money Recap: FedEx, Costco, Nike

Jim Cramer says this is a rough season for stock, and investors need to take defensive action.

anxiety grocery mask sh

Jensen: Economy Has a Bearish Outlook

Real Money's Bret Jensen says a slower-than-expected pandemic recovery is a warning for the stock market.

Pfizer vaccine Lead

FDA Panel Recommends Covid Booster Shots for 65, Older and Those at High Risk

Food and Drug Administration's advisory panel on Friday voted to recommend Covid-19 booster shots of the Pfizer vaccine for a limited section of the population.

Ford Lead

Stock Market Today With Jim Cramer: How to Trade Ford

Jim Cramer discusses Ford and the impact of the impending tax policy changes on the stock market.

Jim Cramer: Stay Long Thermo Fisher, Sell FEI

Thermo Fisher Climbs on Strong 2022 Guidance

Thermo Fisher expects revenue to increase 12% year over year next year to $40.3 billion.